All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-WFY2696 | Anti-CCNT2 (CBFYC-1060) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-1060 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2697 | Anti-CCNT2 (CBFYC-1061) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-1061 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2698 | Anti-CCNT2 (CBFYC-1062) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-1062 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5949 | Anti-CCNT2 (CBFYC-1060) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-1060 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5950 | Anti-CCNT2 (CBFYC-1061) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-1061 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY5951 | Anti-CCNT2 (CBFYC-1062) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-1062 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-0320ZP529 | Anti-CCNT2 (8C95) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 8C95 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP530 | Anti-CCNT2 (8C95) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 8C95 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP531 | Anti-CCNT2 (1H3) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 1H3 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP532 | Anti-CCNT2 (1H3) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 1H3 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP533 | Anti-CCNT2 (2128C1a) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | 2128C1a | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0320ZP534 | Anti-CCNT2 (2128C1a) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | 2128C1a | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION